Return to Article Details
THE USE OF ANTITUBERCULOSIS THERAPY CAUSES AN INCREASE OF URIC ACID LEVELS IN PATIENTS WITH TB-MDR (TUBERCULOSIS MULTI DRUG RESISTANT)
Download
Download PDF